Abstract:To determine the effect of short-term culture in IVM medium on oocyte maturation, subsequent embryonic development and the clinical outcome. A prospective study was conducted under the following background. Current standard stimulation protocols use gonadotropins (recombinant or hMG) combined with LHRH agonists to prevent the problem of premature ovulation with the aim of obtaining an average of 10–15 mature oocytes per retrieval. However, it is quite often containing some immature oocytes retrieved with mature oocytes even after triggering of LH surge. Practically those immature oocytes retrieved were discarded. Insemination is performed normally after approximately 41 h of HCG injection. Therefore, there is a few hours (3-5 h) after oocyte retrieval before insemination in fertilization medium (FM). We do not know whether or not FM is suitable for final oocyte maturation. Forty-five infertile women under 35 years of age were enrolled in this study. All the patients underwent autologous intracytoplasmic sperm injection (ICSI) cycles with more than 2 cycles failed previously. GnRH antagonist protocol was used for controlled ovarian hyperstimulation. Twelve patients were enrolled in the treated group, the COCs were cultured in balanced IVM medium (IVM Kit, SAGE, Coopersurgical, USA) immediately after retrieval for 4 hours in 5% CO2, 5% O2, 90% N2at 37oC incubator before ICSI. Those thirty-there untreated patients underwent conventional ICSI with a similar duration of incubation in FM before ICSI. The oocyte maturation rate was compared in the two groups, and subsequent fertilization rate, early embryonic development and the pregnancy rate were also determined. The maturation rate was 72.1%(98/136) and 69.8%(233/334) in treated and untreated groups. The fertilization rate, usable embryo rate, good quality embryo rate, blastocyst formation rate as well as biochemical and clinical pregnancy rate were 72.4%(71/98) vs 69.1%(161/233), 78.9%(56/71) vs 59.0%(95/161) (P<0.1), 52.1%(37/71) vs 33.5%(54/161) (P<0.1), 60.6%(20/33) vs 57.9%(22/38), 57.1%(4/7) vs 35.7%(10/28) and 42.9%(3/7) vs 35.7%(10/28) respectively. Short-term IVM culture of COCs remarkably improves the usable embryo rate and good quality embryo rate, subsequently could obtain higher proportion of good quality embryos for transfer, thereby improves pregnancy rate.

Development in application of In-vitro maturation culture of immature oocytes for infertile women with polycystic ovary syndrome

In Vitro Maturation and Fertilization of Oocytes from Unstimulated Cycles in Women with Infertility Due to Polycystic Ovary Syndrome

A Research of Treating Infertile PCOS Women with Oocyte in Vitro Maturation

Clinical study on the application of in vitro maturation treatment in the patients with follicle development retardation in in vitro fertilization cycles

Improved Developmental Competence and Spindle Assembly of in Vitro Maturation of Human Oocytes by Prolonged Culture Duration

Clinical Outcomes of <i>In Vitro</i> Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study

Development of frozen-thawed embryos derived from immature human oocytes following in-vitro maturation and fertilization in women with PCOS

Pregnancy Outcomes in Women with Polycystic Ovary Syndrome after in vitro Oocyte Maturation

In Vitro Maturation of Human Immature Oocyte in IVF-ET As a Compensatory Method

Observation on pregnancy acquired by in vitro maturation of human immatured oocytes treated with human umbilical cord serum

Comparison of two in vitro gonadotrophin priming protocols in maturation treatment of patients with polycystic ovary syndrome

Clinical Outcomes of In Vitro Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study

[In Vitro Maturation--n Vitro Fertilization--embryo Transfer--frozen-thawed of Human Oocytes].

Oocyte in vitro maturation: physiological basis and application to clinical practice

Research Progress of In Vitro Maturation of Human Immature Oocytes

SORT-TERM <i>IN VITRO</i> MATURATION (IVM) CULTURE OF CUMULUS-OOCYTE COMPLEXES IMPROVES SUBSEQUENT EMBRYONIC DEVELOPMENT IN STIMULATED CYCLES.

Current perspectives on in vitro maturation and its effects on oocyte genetic and epigenetic profiles

Exploring the Potential of In vitro Maturation (IVM) of Oocytes: Indications, Applications, and Treatment Protocols

Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hcg) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome

Fertilization of in Vitro Matured Human Oocytes by Intracytoplasmic Sperm Injection （ICSI） Using Ejaculated and Testicular Spermatozoa

Research on the In Vitro Maturation and Vitrification of Oocytes from Human Luteal Phase